返回首页
TechCrunch AI··行业媒体

OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

中文摘要

OpenAI 收购 Orchestra Bio 以强化生物技术业务,通过整合其技术提升 Rosalind AI 模型及工作台,助力生命科学研究与实验分析。

English Summary

OpenAI acquired Orchestra Bio to bolster its biotech business, integrating their technology into the Rosalind AI model and Workbench to assist life sciences research and experiment analysis.

原文节选

OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.